XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Dialysis and related lab patient service revenues $ 2,635,152 $ 2,591,074
Provision for uncollectible accounts (5,463) 25,545
Net dialysis and related lab patient service revenues 2,629,689 2,616,619
Other revenues 113,423 232,825
Total revenues 2,743,112 2,849,444
Operating expenses and charges:    
Patient care costs 1,964,935 2,035,585
General and administrative 250,813 266,529
Depreciation and amortization 148,528 142,799
Equity investment income (2,708) (155)
Provision for uncollectible accounts 0 (6,000)
Goodwill impairment charges 41,037 0
Total operating expenses and charges 2,402,605 2,438,758
Operating income 340,507 410,686
Debt expense (131,519) (113,516)
Other income, net 6,940 4,582
Income from continuing operations before income taxes 215,928 301,752
Income tax expense 56,746 70,737
Net income from continuing operations 159,182 231,015
Net income (loss) from discontinued operations, net of tax 30,305 (5,786)
Net income 189,487 225,229
Less: Net income attributable to noncontrolling interests (40,198) (46,543)
Net income attributable to DaVita Inc. $ 149,289 $ 178,686
Earnings per share attributable to DaVita Inc.:    
Basic net income from continuing operations per share $ 0.72 $ 1.07
Basic net income per share 0.90 1.00
Diluted net income from continuing operations per share 0.72 1.05
Diluted net income per share $ 0.90 $ 0.98
Weighted average shares for earnings per share:    
Basic (in shares) 166,387,958 178,957,865
Diluted (in shares) 166,780,657 181,834,547
Amounts attributable to DaVita Inc.:    
Net income from continuing operations $ 120,254 $ 191,015
Net income (loss) from discontinued operations 29,035 (12,329)
Net income attributable to DaVita Inc. $ 149,289 $ 178,686